Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1073638

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1073638

Precision Medicine Market, By Technology, By Application (Oncology, Central Nervous System, Hematology, Respiratory, Immunology, and Others)), and By Region - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027

PUBLISHED:
PAGES: 170 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Precision medicine guides disease diagnosis, treatment, and prevention of cancer, hereditary diseases, and other disorders based on an individual's unique clinical, molecular, and lifestyle information. Doctors and researchers will be able to predict more accurately which treatment and prevention methods for a specific disease will work in which groups of people using this approach. Through the use of pharmacogenomics, which analyses patient data to guide effective and safe medication plans for patients, precision medicine has the potential to enhance population health and lower overall healthcare costs. The detailed characterization of human biology is now possible owing to innovations in biomarkers, bioimaging, and wearable technologies. Clinicians employ a combination of genomic data, health records, lab tests, and other patient data to help personalise therapy in precision medicine. In this way they will be able to offer the appropriate treatment to the appropriate patient at the appropriate time.

Market Dynamics

The increasing adoption of inorganic strategies such as collaborations and partnerships by the key players in the market is expected to drive the global precision medicine market over the forecast period. For instance, in September 2020, Thermo Fisher Scientific Inc., the world leader in serving science, announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca, a multinational pharmaceutical and Biotechnology Company, and the University of Nebraska Medical Center, a public medical school in Omaha, Nebraska. The new collaboration will help strengthen the PMSC's mission of creating standardized workflows with pharma and academic partners to create new opportunities for precision medicine.

Key features of the study:

  • This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundation Medicine, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market

Detailed Segmentation:

  • Global Precision Medicine Market, By Technology:
    • Bioinformatics
    • Gene Sequencing
    • Drug Discovery
    • Precision Molecular Diagnostics
    • Big Data Analytics
  • Global Precision Medicine Market, By Application:
    • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
    • Central Nervous System
    • Hematology
    • Respiratory
    • Immunology
    • Others
  • Global Precision Medicine Market, By Region:
    • North America
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Technology
      • Bioinformatics
      • Gene Sequencing
      • Drug Discovery
      • Precision Molecular Diagnostics
      • Big Data Analytics
      • By Application
      • Oncology
      • Breast Cancer
      • Lung Cancer
      • Others
      • Central Nervous System
      • Hematology
      • Respiratory
      • Immunology
      • Others
      • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Intomics
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GENinCode
    • NanoString
    • Tepnel Pharma Services Limited
    • Pfizer Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • Merck & Co., Inc
    • QIAGEN
    • Quest Diagnostics Incorporated
    • Medtronic
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • bioMerieux SA
    • F. Hoffmann-La Roche Ltd
    • Eli Lilly & Company
    • GlaxoSmithKline plc
    • Cepheid
    • AstraZeneca PLC
    • Myriad Genetics, Inc.
    • Bristol-Myers Squibb Company
    • Foundation Medicine, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI145

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Acquisitions and Partnerships Scenario
  • Ongoing Developments
  • Porter's Analysis
  • PEST Analysis

4. Global Precision Medicine Market- COVID-19 Impact Analysis

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Precision Medicine Market, By Technology, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Bioinformatics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Gene Sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Drug Discovery
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Precision Molecular Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Big Data Analytics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Precision Medicine Market, By Application, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
    • Breast Cancer
    • Lung Cancer
    • Others
  • Central Nervous System
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Hematology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Respiratory
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Immunology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Precision Medicine Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

    • Intomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • GENinCode
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • NanoString
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Tepnel Pharma Services Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Merck & Co., Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Quest Diagnostics Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Laboratory Corporation of America Holdings
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategie
    • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Eli Lilly & Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • GlaxoSmithKline plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Cepheid
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • AstraZeneca PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Myriad Genetics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Bristol-Myers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Foundation Medicine, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!